Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Erasca Inc. Common Stock (ERAS) vs UnitedHealth Group Inc (UNH) Price & Performance

Erasca Inc. Common StockTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

Erasca Inc. Common Stock vs UnitedHealth Group Inc — how do they compare? Erasca Inc. Common Stock trades at $16.03 (market cap $5.40B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 61.7× Erasca Inc. Common Stock's market cap, and UnitedHealth Group Inc pays a 2.5% dividend while Erasca Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and UnitedHealth Group Inc for 97 Days on average.

ERASUNH
Market Cap
$5.40B$332.96B
Volume
9,533,1857,273,749
Sector
HealthHealth
52-Week High
$22.47$436.35
52-Week Low
$2.20$259.02
Typical Hold Time
0 Days97 Days
Enterprise Value
$5.18B$374.82B
Dividend Yield
—2.5%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Erasca Inc. Common Stock

No Aura AI signal available yet.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.

UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ERAS
50% Buy50% Sell
Avg holding period · 0 Days
UNH
71% Buy29% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About Erasca Inc. Common Stock

Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.

Read more on ERAS →

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH →